Serefko, A.; Bielecka-Papierz, G.; Talarek, S.; Szopa, A.; Skałecki, P.; Szewczyk, B.; Radziwoń-Zaleska, M.; Poleszak, E.
Central Effects of the Designer Drug Mephedrone in Mice—Basic Studies. Brain Sci. 2022, 12, 189.
https://doi.org/10.3390/brainsci12020189
AMA Style
Serefko A, Bielecka-Papierz G, Talarek S, Szopa A, Skałecki P, Szewczyk B, Radziwoń-Zaleska M, Poleszak E.
Central Effects of the Designer Drug Mephedrone in Mice—Basic Studies. Brain Sciences. 2022; 12(2):189.
https://doi.org/10.3390/brainsci12020189
Chicago/Turabian Style
Serefko, Anna, Gabriela Bielecka-Papierz, Sylwia Talarek, Aleksandra Szopa, Piotr Skałecki, Bernadeta Szewczyk, Maria Radziwoń-Zaleska, and Ewa Poleszak.
2022. "Central Effects of the Designer Drug Mephedrone in Mice—Basic Studies" Brain Sciences 12, no. 2: 189.
https://doi.org/10.3390/brainsci12020189
APA Style
Serefko, A., Bielecka-Papierz, G., Talarek, S., Szopa, A., Skałecki, P., Szewczyk, B., Radziwoń-Zaleska, M., & Poleszak, E.
(2022). Central Effects of the Designer Drug Mephedrone in Mice—Basic Studies. Brain Sciences, 12(2), 189.
https://doi.org/10.3390/brainsci12020189